ACCORD BIOPHARMA INC

FDA Regulatory Profile

ACCORD BIOPHARMA INC appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0653-2026, Class II) was initiated on June 10, 2026.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Known Names

accord biopharma, accord biopharma inc

Recent Recalls

NumberClassProductDate
D-0653-2026Class IIIMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, ManufacturJune 10, 2026